메뉴 건너뛰기




Volumn 9, Issue 6, 2005, Pages 933-942

Process development challenges to accommodate a late-appearing stable polymorph: A case study on the polymorphism and crystallization of a fast-track drug development compound

Author keywords

[No Author keywords available]

Indexed keywords


EID: 28944454413     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op0501287     Document Type: Article
Times cited : (38)

References (8)
  • 3
    • 0034345221 scopus 로고    scopus 로고
    • Dealing with the impact of Ritonovir Polymorphs on the Late Stages of Bulk Drug Process Development
    • Chemburkar, S. R. et al. Dealing with the impact of Ritonovir Polymorphs on the Late Stages of Bulk Drug Process Development. Org. Process Res. Dev. 2000, 4, 413-417.
    • (2000) Org. Process Res. Dev. , vol.4 , pp. 413-417
    • Chemburkar, S.R.1
  • 4
    • 0037423345 scopus 로고    scopus 로고
    • General Scope of 1,4-Diastereoselective Additions to a 2(3H)-Quinazolinone: Practical Preparation of HIV Therapeutics
    • Magnus, N. A.; Confalone, P. N.; Storace, L.; Patel, M.; Wood, C. C.; Davis, W. P.; Parsons, Rodney, L., Jr. General Scope of 1,4-Diastereoselective Additions to a 2(3H)-Quinazolinone: Practical Preparation of HIV Therapeutics. J. Org. Chem. 2003, 68, 754-761.
    • (2003) J. Org. Chem. , vol.68 , pp. 754-761
    • Magnus, N.A.1    Confalone, P.N.2    Storace, L.3    Patel, M.4    Wood, C.C.5    Davis, W.P.6    Parsons Jr., R.L.7
  • 5
    • 0034701536 scopus 로고    scopus 로고
    • A new asymmetric 1,4-addition method: Application to the synthesis of the HIV nonnucleoside reverse transcriptase inhibitor
    • Magnus, N. A.; Confalone, P. N.; Storace, L. A new asymmetric 1,4-addition method: Application to the synthesis of the HIV nonnucleoside reverse transcriptase inhibitor. Tetrahedron Lett. 2000, 41(17), 3015-3019.
    • (2000) Tetrahedron Lett. , vol.41 , Issue.17 , pp. 3015-3019
    • Magnus, N.A.1    Confalone, P.N.2    Storace, L.3
  • 6
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12, 413-420.
    • (1995) Pharm. Res. , vol.12 , pp. 413-420
    • Amidon, G.L.1    Lennernas, H.2    Shah, V.P.3    Crison, J.R.4
  • 7
    • 0018625999 scopus 로고
    • On the Polymorphism of Pharmaceutical and Other Molecular Crystals. I. Theory of Thermodynamic Rules
    • Burger A.; Ramberger, R. On the Polymorphism of Pharmaceutical and Other Molecular Crystals. I. Theory of Thermodynamic Rules. Mikrochim. Acta [Wein] 1979, II, 259-271.
    • (1979) Mikrochim. Acta [Wein] , vol.2 , pp. 259-271
    • Burger, A.1    Ramberger, R.2
  • 8
    • 0018618861 scopus 로고
    • On the Polymorphism of Pharmaceutical and Other Molecular Crystals. II. Applicability of Thermodynamic Rules
    • Burger A.; Ramberger, R. On the Polymorphism of Pharmaceutical and Other Molecular Crystals. II. Applicability of Thermodynamic Rules. Mikrochim. Acta [Wein] 1979, II, 273-316.
    • (1979) Mikrochim. Acta [Wein] , vol.2 , pp. 273-316
    • Burger, A.1    Ramberger, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.